[Early differential diagnosis and restorative treatment of cerebral palsy]

S A Nemkova1, V G Boldyrev1

  • 1Pirogov Russian National Research Medical University, Moscow, Russia.

Insights

Early diagnosis and comprehensive treatment of cerebral palsy (CP) are crucial. Cortexin demonstrates high efficacy in managing motor, cognitive, and autonomic disorders in children with CP.

Area of Science:

  • Neurology
  • Developmental Pediatrics

Context:

  • Cerebral palsy (CP) presents a significant challenge in modern neurology, necessitating early diagnosis and effective treatment strategies.
  • Accurate differential diagnosis in infants is vital to distinguish CP from other conditions like hereditary-metabolic and neuromuscular diseases.

Purpose:

  • To detail the etiological factors and pathogenetic mechanisms underlying various forms of cerebral palsy.
  • To review current diagnostic capabilities for early identification of cerebral palsy in infants.
  • To present leading approaches in the complex rehabilitation of cerebral palsy, aligned with current standards and clinical guidelines.

Summary:

  • The article examines the causes and development of different types of cerebral palsy.
  • It highlights modern methods for differentiating cerebral palsy from other pediatric conditions in early life.
  • Key rehabilitation strategies for cerebral palsy are discussed, emphasizing evidence-based practices.

Impact:

  • The drug Cortexin shows significant efficacy in treating motor, cognitive, and autonomic dysfunction in children with cerebral palsy.
  • Cortexin's multimodal action, including neuropreparation, neuroprotection, and neuroplasticity, supports its therapeutic benefits.
  • This research underscores the importance of integrated treatment approaches for improving outcomes in pediatric cerebral palsy.

Related Concept Videos